Stock Research for HTBX

HTBX
Current Price

$2.6000


Latest Update: 2018-02-23 16:00:00

High
$ 2.6005
Low
$ 2.6000
Close
$ 2.6005
Volume
766
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

HTBX Stock Chart & Research Data

The HTBX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HTBX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


HTBX Due diligence Resources & Stock Charts

The HTBX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View HTBX Detailed Price Forecast - CNN Money CNN View HTBX Detailed Summary - Google Finance
Yahoo View HTBX Detailed Summary - Yahoo! Finance Zacks View HTBX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View HTBX Trends & Analysis - Trade-Ideas Barrons View HTBX Major Holders - Barrons
NASDAQ View HTBX Call Transcripts - NASDAQ Seeking View HTBX Breaking News & Analysis - Seeking Alpha
Spotlight View HTBX Annual Report - CompanySpotlight.com OTC Report View HTBX OTC Short Report - OTCShortReport.com
TradeKing View HTBX Fundamentals - TradeKing Charts View HTBX SEC Filings - Bar Chart
WSJ View Historical Prices for HTBX - The WSJ Morningstar View Performance/Total Return for HTBX - Morningstar
MarketWatch View the Analyst Estimates for HTBX - MarketWatch CNBC View the Earnings History for HTBX - CNBC
StockMarketWatch View the HTBX Earnings - StockMarketWatch MacroAxis View HTBX Buy or Sell Recommendations - MacroAxis
Bullish View the HTBX Bullish Patterns - American Bulls Short Pains View HTBX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View HTBX Stock Mentions - StockTwits PennyStocks View HTBX Stock Mentions - PennyStockTweets
Twitter View HTBX Stock Mentions - Twitter Invest Hub View HTBX Investment Forum News - Investor Hub
Yahoo View HTBX Stock Mentions - Yahoo! Message Board Seeking Alpha View HTBX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for HTBX - SECform4.com Insider Cow View Insider Transactions for HTBX - Insider Cow
CNBC View HTBX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for HTBX - OTC Markets
Yahoo View Insider Transactions for HTBX - Yahoo! Finance NASDAQ View Institutional Holdings for HTBX - NASDAQ


Stock Charts

FinViz View HTBX Stock Insight & Charts - FinViz.com StockCharts View HTBX Investment Charts - StockCharts.com
BarChart View HTBX Stock Overview & Charts - BarChart Trading View View HTBX User Generated Charts - Trading View


Latest Financial News for HTBX

Heat Biologics Receives Recommendation from Independent Data Monitoring Committee to Continue Enrollment of Phase 2 Clinical Trial for HS-110 and Nivolumab for Treatment of Non-small Cell Lung Cancer
Posted on Tuesday February 20, 2018

DURHAM, NC / ACCESSWIRE / February 20, 2018 / Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against ...


Heat Biologics Announces Poster Presentation of Interim Phase 2 Lung Cancer Clinical Data for HS-110 and Nivolumab at the 2018 Keystone Symposia Conference XI: Immunological Memory: Innate, Adaptive and Beyond
Posted on Wednesday February 14, 2018

DURHAM, NC / ACCESSWIRE / February 14, 2018 / Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against ...


Heat Biologics CEO, Jeff Wolf, to Present at the Upcoming BIO CEO & Investor Conference in New York
Posted on Wednesday February 07, 2018

DURHAM, NC / ACCESSWIRE / February 7, 2018 / Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against ...


Today’s Research Reports on Trending Tickers: Heat Biologics and ImmunoGen
Posted on Thursday February 01, 2018

NEW YORK, NY / ACCESSWIRE / February 1, 2018 / U.S. markets rallied late Wednesday to close in the green, with the Dow Jones and S&P 500 posting their best monthly gain since March 2016. The Dow Jones ...


What Can We Expect for Heat Biologics Inc (NASDAQ:HTBX) Moving Forward?
Simply Wall St - Feb 12, 2018
Heat Biologics Inc (NASDAQ:HTBX), a US$10.96M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an aging population, impacting the sector ...
Heat Biologics, Inc. (HTBX): A Detailed Look at its Institutional Ownership - Post Analyst
After Reaching Milestone, Is Heat Biologics Incorporated (NASDAQ:HTBX)'s Short ... - Reurope

Does Heat Biologics, Inc. (HTBX) Have Any Gas After Reaching 52 Week Low?
Frisco Fastball - 17 hours ago
60,500 were reported by Franklin Street Nc. Two Sigma Secs Lc reported 21,663 shares stake. Moreover, Geode Cap Management Ltd has 0% invested in Heat Biologics, Inc. (NASDAQ:HTBX) for 79,837 shares. Northern reported 25,304 shares stake. 74,154 are ...
ValuEngine Lowers Heat Biologics (HTBX) to Strong Sell - The Ledger Gazette
What Story Are The Numbers Telling For Heat Biologics, Inc. (NasdaqCM:HTBX) - Newberry Journal

Form 8-K HEAT BIOLOGICS, INC. For: Feb 20
StreetInsider.com - Feb 20, 2018
These statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ ...
Heat Biologics, Inc. (HTBX)'s Trend Up, Especially After Today's Strong Session - Frisco Fastball
Is Buying Stock Like Heat Biologics, Inc. (HTBX) After Such Increase Winning ... - BZ Weekly

1 hedge funds buy Heat Biologics, Inc. (HTBX) for the first time
Post Analyst - Feb 22, 2018
Heat Biologics, Inc. (NASDAQ:HTBX) has made a 19.08% comeback from a 12-month low price of $2.52. It was seen -8.54% lower, changing the price to $3, when the closing bell rang on 02/21/2018.

Enter a stock symbol to view the stock details.